tirzepatide cause itching Injection Site Red and Itchy: Causes and Solutions Welp, just discovered this. Severe

Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial [published correction appears in Lancet

Are wellness treatments safe

[9] Per the British National Formulary it is also less preferred than a sulfonylurea as of 2019, while the American Diabetes Association and European Association for the Study of Diabetes consider either a SGLT2 inhibitor or GLP-1 receptor agonist a reasonable second line medication in those with heart disease

Its important to note that the choice of GLP-1 medication should be made in consultation with a healthcare provider, taking into account individual patient factors, medical history, and treatment goals